Abstract
Introduction
Adipose tissue and adipocytes are primary regulators of insulin sensitivity and energy homeostasis. Defects in insulin sensitivity of the adipocytes predispose the body to insulin resistance (IR) that could lead to diabetes. However, the mechanisms mediating adipocyte IR remain elusive, which emphasizes the need to develop experimental models that can validate the insulin signaling pathways and discover new mechanisms in the search for novel therapeutics. Currently in vitro adipose organ-chip devices show superior cell function over conventional cell culture. However, none of these models represent disease states. Only when these in vitro models can represent both healthy and disease states, they can be useful for developing therapeutics. Here, we establish an organ-on-chip model of insulin-resistant adipocytes, as well as characterization in terms of insulin signaling pathway and lipid metabolism.
Methods
We differentiated, maintained, and induced insulin resistance into primary adipocytes in a microfluidic organ-on-chip. We then characterized IR by looking at the insulin signaling pathway and lipid metabolism, and validated by studying a diabetic drug, rosiglitazone.
Results
We confirmed the presence of insulin resistance through reduction of Akt phosphorylation, Glut4 expression, Glut4 translocation and glucose uptake. We also confirmed defects of disrupted insulin signaling through reduction of lipid accumulation from fatty acid uptake and elevation of glycerol secretion. Testing with rosiglitazone showed a significant improvement in insulin sensitivity and fatty acid metabolism as suggested by previous reports.
Conclusions
The adipose-chip exhibited key characteristics of IR and can serve as model to study diabetes and facilitate discovery of novel therapeutics.
Similar content being viewed by others
References
Abbott, R. D., W. K. Raja, R. Y. Wang, J. A. Stinson, D. L. Glettig, K. A. Burke, and D. L. Kaplan. Long term perfusion system supporting adipogenesis. Methods 84:84–89, 2015.
Adebonojo, F. O. Studies on human adipose cells in culture: relation of cell size and multiplication to donor age. Yale J. Biol. Med. 48(1):9–16, 1975.
Al-Awar, A., K. Kupai, M. Veszelka, G. Szucs, Z. Attieh, Z. Murlasits, S. Torok, A. Posa, and C. Varga. Experimental diabetes mellitus in different animal models. J. Diabetes Res. 2016:9051426, 2016.
Asada, S., M. Kuroda, Y. Aoyagi, Y. Fukaya, S. Tanaka, S. Konno, M. Tanio, M. Aso, K. Satoh, Y. Okamoto, T. Nakayama, Y. Saito, and H. Bujo. Ceiling culture-derived proliferative adipocytes retain high adipogenic potential suitable for use as a vehicle for gene transduction therapy. Am. J. Physiol. 301(1):C181–C185, 2011.
Aune, U. L., L. Ruiz, and S. Kajimura. Isolation and differentiation of stromal vascular cells to beige/brite cells. J. Visual. Exp. 73:e50191, 2013.
Bjorndal, B., L. Burri, V. Staalesen, J. Skorve, and R. K. Berge. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J. Obes. 2011:490650, 2011.
Boutens, L., and R. Stienstra. Adipose tissue macrophages: going off track during obesity. Diabetologia 59(5):879–894, 2016.
Boyle, J. P., T. J. Thompson, E. W. Gregg, L. E. Barker, and D. F. Williamson. Projection of the year 2050 burden of diabetes in the us adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 8(1):29, 2010.
Cawthorn, W. P., and J. K. Sethi. Tnf-alpha and adipocyte biology. FEBS Lett. 582(1):117–131, 2008.
Chen, F. C., K. P. Shen, J. B. Chen, H. L. Lin, C. L. Hao, H. W. Yen, and S. Y. Shaw. Pgbr extract ameliorates tnf-alpha induced insulin resistance in hepatocytes. Kaohsiung J. Med. Sci. 34(1):14–21, 2018.
Choi, S. M., D. F. Tucker, D. N. Gross, R. M. Easton, L. M. DiPilato, A. S. Dean, B. R. Monks, and M. J. Birnbaum. Insulin regulates adipocyte lipolysis via an akt-independent signaling pathway. Mol. Cell. Biol. 30(21):5009–5020, 2010.
Cong, L. N., H. Chen, Y. Li, L. Zhou, M. A. McGibbon, S. I. Taylor, and M. J. Quon. Physiological role of akt in insulin-stimulated translocation of glut4 in transfected rat adipose cells. Mol. Endocrinol. 11(13):1881–1890, 1997.
Cusi, K., K. Maezono, A. Osman, M. Pendergrass, M. E. Patti, T. Pratipanawatr, R. A. DeFronzo, C. R. Kahn, and L. J. Mandarino. Insulin resistance differentially affects the pi 3-kinase- and map kinase-mediated signaling in human muscle. J. Clin. Invest. 105(3):311–320, 2000.
Edington, C. D., W. L. K. Chen, E. Geishecker, T. Kassis, L. R. Soenksen, B. M. Bhushan, D. Freake, J. Kirschner, C. Maass, N. Tsamandouras, J. Valdez, C. D. Cook, T. Parent, S. Snyder, J. Yu, E. Suter, M. Shockley, J. Velazquez, J. J. Velazquez, L. Stockdale, J. P. Papps, I. Lee, N. Vann, M. Gamboa, M. E. LaBarge, Z. Zhong, X. Wang, L. A. Boyer, D. A. Lauffenburger, R. L. Carrier, C. Communal, S. R. Tannenbaum, C. L. Stokes, D. J. Hughes, G. Rohatgi, D. L. Trumper, M. Cirit, and L. G. Griffith. Interconnected microphysiological systems for quantitative biology and pharmacology studies. Sci. Rep. 8(1):4530, 2018.
Engin, A. B. Adipocyte-macrophage cross-talk in obesity. Adv. Exp. Med. Biol. 960:327–343, 2017.
Fain, J. N., V. P. Kovacev, and R. O. Scow. Antilipolytic effect of insulin in isolated fat cells of the rat. Endocrinology 78(4):773–778, 1966.
Finkelstein, E. A., O. A. Khavjou, H. Thompson, J. G. Trogdon, L. Pan, B. Sherry, and W. Dietz. Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42(6):563–570, 2012.
Godwin, L. A., J. C. Brooks, L. D. Hoepfner, D. Wanders, R. L. Judd, and C. J. Easley. A microfluidic interface for the culture and sampling of adiponectin from primary adipocytes. Analyst 140(4):1019–1025, 2015.
Gonzalez, E., E. Flier, D. Molle, D. Accili, and T. E. McGraw. Hyperinsulinemia leads to uncoupled insulin regulation of the glut4 glucose transporter and the foxo1 transcription factor. Proc. Natl. Acad. Sci. USA 108(25):10162–10167, 2011.
Green, A., J. M. Rumberger, C. A. Stuart, and M. S. Ruhoff. Stimulation of lipolysis by tumor necrosis factor-alpha in 3t3-l1 adipocytes is glucose dependent: implications for long-term regulation of lipolysis. Diabetes 53(1):74–81, 2004.
Guedes, J. A. C., J. V. Esteves, M. R. Morais, T. M. Zorn, and D. T. Furuya. Osteocalcin improves insulin resistance and inflammation in obese mice: participation of white adipose tissue and bone. Bone 115:68–82, 2018.
Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9(5):367–377, 2008.
Hernandez, R., T. Teruel, C. de Alvaro, and M. Lorenzo. Rosiglitazone ameliorates insulin resistance in brown adipocytes of wistar rats by impairing tnf-alpha induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47(9):1615–1624, 2004.
Hoehn, K. L., C. Hohnen-Behrens, A. Cederberg, L. E. Wu, N. Turner, T. Yuasa, Y. Ebina, and D. E. James. Irs1-independent defects define major nodes of insulin resistance. Cell. Metab. 7(5):421–433, 2008.
Hotamisligil, G. S., D. L. Murray, L. N. Choy, and B. M. Spiegelman. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91(11):4854–4858, 1994.
Hotamisligil, G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman. Irs-1-mediated inhibition of insulin receptor tyrosine kinase activity in tnf-alpha- and obesity-induced insulin resistance. Science 271(5249):665–668, 1996.
Hube, F., and H. Hauner. The role of tnf-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm. Metab. Res. 31(12):626–631, 1999.
Huh, D., G. A. Hamilton, and D. E. Ingber. From 3d cell culture to organs-on-chips. Trends Cell Biol. 21(12):745–754, 2011.
Hupfeld, C. J., C. H. Courtney, and J. M. Olefsky. Type 2 diabetes mellitus: etiology, pathogenesis, and natural history. In: Endocrinology, edited by L.J. DeGroot. 2010, pp. 765–787
Jager, J., T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J. F. Tanti. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148(1):241–251, 2007.
Jang, M., P. Neuzil, T. Volk, A. Manz, and A. Kleber. On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro. Biomicrofluidics 9(3):034113, 2015.
Jiang, G., Q. Dallas-Yang, S. Biswas, Z. Li, and B. B. Zhang. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (ppargamma), decreases inhibitory serine phosphorylation of irs1 in vitro and in vivo. Biochem. J. 377(Pt 2):339–346, 2004.
Jiang, Z. Y., Q. L. Zhou, K. A. Coleman, M. Chouinard, Q. Boese, and M. P. Czech. Insulin signaling through akt/protein kinase b analyzed by small interfering rna-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100(13):7569–7574, 2003.
Kahn, B. B., E. S. Horton, and S. W. Cushman. Mechanism for enhanced glucose transport response to insulin in adipose cells from chronically hyperinsulinemic rats: increased translocation of glucose transporters from an enlarged intracellular pool. J. Clin. Invest. 79(3):853–858, 1987.
Kahn, S. E., R. L. Hull, and K. M. Utzschneider. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840–846, 2006.
Karlsson, H. K., K. Hallsten, M. Bjornholm, H. Tsuchida, A. V. Chibalin, K. A. Virtanen, O. J. Heinonen, F. Lonnqvist, P. Nuutila, and J. R. Zierath. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. Diabetes 54(5):1459–1467, 2005.
Kimura, H., Y. Sakai, and T. Fujii. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab. Pharmacokinet. 33(1):43–48, 2018.
King, A. J. The use of animal models in diabetes research. Br. J. Pharmacol. 166(3):877–894, 2012.
Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. Expression of a constitutively active akt ser/thr kinase in 3t3-l1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271(49):31372–31378, 1996.
Lahey, R., and S. S. Khan. Trends in obesity and risk of cardiovascular disease. Curr. Epidemiol. Rep. 5(3):243–251, 2018.
Laviola, L., S. Perrini, A. Cignarelli, A. Natalicchio, A. Leonardini, F. De Stefano, M. Cuscito, M. De Fazio, V. Memeo, V. Neri, M. Cignarelli, R. Giorgino, and F. Giorgino. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. Diabetes 55(4):952–961, 2006.
Lessard, J., M. Pelletier, L. Biertho, S. Biron, S. Marceau, F. S. Hould, S. Lebel, F. Moustarah, O. Lescelleur, P. Marceau, and A. Tchernof. Characterization of dedifferentiating human mature adipocytes from the visceral and subcutaneous fat compartments: fibroblast-activation protein alpha and dipeptidyl peptidase 4 as major components of matrix remodeling. PLoS ONE 10(3):e0122065, 2015.
Li, S., M. S. Brown, and J. L. Goldstein. Bifurcation of insulin signaling pathway in rat liver: Mtorc1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 107(8):3441–3446, 2010.
Li, X., and C. J. Easley. Microfluidic systems for studying dynamic function of adipocytes and adipose tissue. Anal. Bioanal. Chem. 410(3):791–800, 2018.
Liu, Y., P. Kongsuphol, S. B. N. Gourikutty, and Q. Ramadan. Human adipocyte differentiation and characterization in a perfusion-based cell culture device. Biomed. Microdevices 19(3):18, 2017.
Liu, T., B. Yu, M. Kakino, H. Fujimoto, Y. Ando, F. Hakuno, and S.-I. Takahashi. A novel irs-1-associated protein, dgkζ regulates glut4 translocation in 3t3-l1 adipocytes. Sci. Rep. 6(1):35438, 2016.
Loskill, P., T. Sezhian, K. M. Tharp, F. T. Lee-Montiel, S. Jeeawoody, W. M. Reese, P. H. Zushin, A. Stahl, and K. E. Healy. Wat-on-a-chip: a physiologically relevant microfluidic system incorporating white adipose tissue. Lab. Chip 17(9):1645–1654, 2017.
Lu, S., C. E. Dugan, and R. T. Kennedy. Microfluidic chip with integrated electrophoretic immunoassay for investigating cell–cell interactions. Anal. Chem. 90(8):5171–5178, 2018.
Malinowski, J. M., and S. Bolesta. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 22(10):1151–1168, 2000; (discussion 1149-1150).
Marshall, S. Kinetics of insulin action on protein synthesis in isolated adipocytes. Ability of glucose to selectively desensitize the glucose transport system without altering insulin stimulation of protein synthesis. J. Biol. Chem. 264(4):2029–2036, 1989.
Martinez, L., M. Berenguer, M. C. Bruce, Y. Le Marchand-Brustel, and R. Govers. Rosiglitazone increases cell surface glut4 levels in 3t3-l1 adipocytes through an enhancement of endosomal recycling. Biochem. Pharmacol. 79(9):1300–1309, 2010.
McDonald, J. C., M. L. Chabinyc, S. J. Metallo, J. R. Anderson, A. D. Stroock, and G. M. Whitesides. Prototyping of microfluidic devices in poly(dimethylsiloxane) using solid-object printing. Anal Chem 74(7):1537–1545, 2002.
Minokoshi, Y., C. R. Kahn, and B. B. Kahn. Tissue-specific ablation of the glut4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J. Biol. Chem. 278(36):33609–33612, 2003.
Mishima, Y., A. Kuyama, A. Tada, K. Takahashi, T. Ishioka, and M. Kibata. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 52(2):119–123, 2001.
Moraes, C., J. M. Labuz, B. M. Leung, M. Inoue, T. H. Chun, and S. Takayama. On being the right size: scaling effects in designing a human-on-a-chip. Integr. Biol. 5(9):1149–1161, 2013.
Morigny, P., M. Houssier, E. Mouisel, and D. Langin. Adipocyte lipolysis and insulin resistance. Biochimie 125:259–266, 2016.
Ng, Y., G. Ramm, and D. E. James. Dissecting the mechanism of insulin resistance using a novel heterodimerization strategy to activate akt. J. Biol. Chem. 285(8):5232–5239, 2010.
Nguyen, M. T., H. Satoh, S. Favelyukis, J. L. Babendure, T. Imamura, J. I. Sbodio, J. Zalevsky, B. I. Dahiyat, N. W. Chi, and J. M. Olefsky. Jnk and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3t3-l1 adipocytes. J. Biol. Chem. 280(42):35361–35371, 2005.
Park, S. Y., Y. R. Cho, H. J. Kim, T. Higashimori, C. Danton, M. K. Lee, A. Dey, B. Rothermel, Y. B. Kim, A. Kalinowski, K. S. Russell, and J. K. Kim. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in c57bl/6 mice. Diabetes 54(12):3530–3540, 2005.
Prodanov, L., R. Jindal, S. S. Bale, M. Hegde, W. J. McCarty, I. Golberg, A. Bhushan, M. L. Yarmush, and O. B. Usta. Long-term maintenance of a microfluidic 3d human liver sinusoid. Biotechnol. Bioeng. 113(1):241–246, 2016.
Qatanani, M., and M. A. Lazar. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21(12):1443–1455, 2007.
Rothbauer, M., H. Zirath, and P. Ertl. Recent advances in microfluidic technologies for cell-to-cell interaction studies. Lab. Chip 18(2):249–270, 2018.
Rotter, V., I. Nagaev, and U. Smith. Interleukin-6 (il-6) induces insulin resistance in 3t3-l1 adipocytes and is, like il-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278(46):45777–45784, 2003.
Ruan, H., N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3t3-l1 adipocytes: nuclear factor-kappab activation by tnf-alpha is obligatory. Diabetes 51(5):1319–1336, 2002.
Ruban, A., K. Stoenchev, H. Ashrafian, and J. Teare. Current treatments for obesity. Clin. Med. (Lond.) 19(3):205–212, 2019.
Ryden, M., and P. Arner. Tumour necrosis factor-alpha in human adipose tissue – from signalling mechanisms to clinical implications. J. Intern. Med. 262(4):431–438, 2007.
Sabio, G., M. Das, A. Mora, Z. Zhang, J. Y. Jun, H. J. Ko, T. Barrett, J. K. Kim, and R. J. Davis. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322(5907):1539–1543, 2008.
Sakoda, H., T. Ogihara, M. Anai, M. Funaki, K. Inukai, H. Katagiri, Y. Fukushima, Y. Onishi, H. Ono, M. Fujishiro, M. Kikuchi, Y. Oka, and T. Asano. Dexamethasone-induced insulin resistance in 3t3-l1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49(10):1700–1708, 2000.
Shen, J. F., A. Sugawara, J. Yamashita, H. Ogura, and S. Sato. Dedifferentiated fat cells: an alternative source of adult multipotent cells from the adipose tissues. Int. J. Oral Sci. 3(3):117–124, 2011.
Shibasaki, M., K. Takahashi, T. Itou, H. Bujo, and Y. Saito. A ppar agonist improves tnf-alpha-induced insulin resistance of adipose tissue in mice. Biochem. Biophys. Res. Commun. 309(2):419–424, 2003.
Shulman, G. I. Cellular mechanisms of insulin resistance. J. Clin. Investig. 106(2):171–176, 2000.
Sugihara, H., N. Yonemitsu, S. Miyabara, and S. Toda. Proliferation of unilocular fat cells in the primary culture. J. Lipid Res. 28(9):1038–1045, 1987.
Sugihara, H., N. Yonemitsu, S. Miyabara, and K. Yun. Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation 31(1):42–49, 1986.
Tan, S. X., K. H. Fisher-Wellman, D. J. Fazakerley, Y. Ng, H. Pant, J. Li, C. C. Meoli, A. C. Coster, J. Stockli, and D. E. James. Selective insulin resistance in adipocytes. J. Biol. Chem. 290(18):11337–11348, 2015.
Tanataweethum, N., A. Zelaya, F. Yang, R. N. Cohen, E. M. Brey, and A. Bhushan. Establishment and characterization of a primary murine adipose tissue-chip. Biotechnol. Bioeng. 115(8):1979–1987, 2018.
Thomson, M. J., M. G. Williams, and S. C. Frost. Development of insulin resistance in 3t3-l1 adipocytes. J. Biol. Chem. 272(12):7759–7764, 1997.
Tremmel, M., U. G. Gerdtham, P. M. Nilsson, and S. Saha. Economic burden of obesity: a systematic literature review. Int. J. Environ. Res. Public Health 14(4):435, 2017.
Wei, S., W. G. Bergen, G. J. Hausman, L. Zan, and M. V. Dodson. Cell culture purity issues and dfat cells. Biochem. Biophys. Res. Commun. 433(3):273–275, 2013.
Wellen, K. E., and G. S. Hotamisligil. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Investig. 112(12):1785–1788, 2003.
Whiteman, E. L., H. Cho, and M. J. Birnbaum. Role of akt/protein kinase b in metabolism. Trends Endocrinol. Metab. 13(10):444–451, 2002.
Zambon, A., A. Zoso, O. Gagliano, E. Magrofuoco, G. P. Fadini, A. Avogaro, M. Foletto, S. Quake, and N. Elvassore. High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. Anal. Chem. 87(13):6535–6543, 2015.
Zhao, Y., R. K. Kankala, S. B. Wang, and A. Z. Chen. Multi-organs-on-chips: towards long-term biomedical investigations. Molecules 24(4):675, 2019.
Acknowledgments
We acknowledge support from the Diabetes Research and Training Center (DRTC) at the University of Chicago. We gratefully acknowledge Dr. Nick Menhart and the Idea shop at Illinois Institute of Technology for technical assistance. We thank Dr. Gokhan Dalgin at University of Chicago for assistance with qPCR.
Funding
This work was supported by DRTC Grant P30 DK020595 and student scholarships from the Armor College of Engineering.
Conflict of interest
Authors Nida Tanataweethum, Franklin Zhong, Allyson Trang, Chaeeun Lee, Ronald N. Cohen, Abhinav Bhushan declare that they have no conflict of interest.
Ethical Approval
The studies were conducted with the approval and in accordance with Institutional Animal Care and Use Committee (IACUC) guidelines. This article does not contain any studies with human participants performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor James L. McGrath oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tanataweethum, N., Zhong, F., Trang, A. et al. Towards an Insulin Resistant Adipose Model on a Chip. Cel. Mol. Bioeng. 14, 89–99 (2021). https://doi.org/10.1007/s12195-020-00636-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-020-00636-x